The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）

NCT07114419 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Obesity and Overweight

Interventions

DRUG: Efsubaglutide Alfa 20 mg QW
DRUG: Efsubaglutide Alfa 40 mg QW
DRUG: Efsubaglutide Alfa 40 mg Q2W
DRUG: Efsubaglutide Alfa 80 mg QW
DRUG: Efsubaglutide Alfa 80 mg Q4W
OTHER: Placebo

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.